Drp1 peptide inhibitor P110

Catalog No.: A57363
Drp1 Inhibitor
Drp1 peptide inhibitor P110 is a selective inhibitor of Dynamin-related protein 1 (Drp1), targeting mitochondrial dynamics. This compound exhibits neuroprotective effects by inhibiting Drp1 activation, preventing MPTP-induced mitochondrial translocation, and mitigating dopaminergic neuron loss along with associated behavioral deficits. Research applications include studies on Alzheimer's disease, as well as models of Huntington's disease, cerebral ischemic injury, and myocardial infarction, where P110 has demonstrated the ability to reduce mitochondrial damage and alleviate organ injury.
Grouped product items
Size Price Stock Qty
1mg
$70.00
In stock
5mg
$190.00
In stock
10mg
$310.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionDrp1 peptide inhibitor P110 is a selective inhibitor of Dynamin-related protein 1 (Drp1), targeting mitochondrial dynamics. This compound exhibits neuroprotective effects by inhibiting Drp1 activation, preventing MPTP-induced mitochondrial translocation, and mitigating dopaminergic neuron loss along with associated behavioral deficits. Research applications include studies on Alzheimer's disease, as well as models of Huntington's disease, cerebral ischemic injury, and myocardial infarction, where P110 has demonstrated the ability to reduce mitochondrial damage and alleviate organ injury.
Product Information
Catalog NumA57363
FormulaC100H179N45O25
Molecular Weight2411.78
CAS Number2770267-63-3
SequenceTyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Asp-Leu-Leu-Pro-Arg-Gly-Ser-NH2
Sequence shorteningYGRKKRRQRRRGGDLLPRGS-NH2
SMILESC([C@@H](NC([C@@H](NC([C@@H](NC(CNC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CC1=CC=C(O)C=C1)N)=O)=O)CCCNC(=N)N)=O)CCCCN)=O)CCCCN)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)=O)=O)CC(O)=O)=O)CC(C)C)=O)CC(C)C)(=O)N2[C@H](C(N[C@H](C(NCC(N[C@H](C(N)=O)CO)=O)=O)CCCNC(=N)N)=O)CCC2
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2